|
Treatment and care aspects in biological attack with plague
|
| |
|
|
|
Abstract: (6800 Views) |
| Introduction: Bioterrorism and its potential for mass death is a proposed and important new concept today. Biological attack is a phenomenon that started in the twentieth century, and apparently not be stopped. Plague agent is one of the bioweapon factors listed in by the Convention of disarmament. Hence, the risk of its biological or Bioterrorist application by enemy is a possible and serious threat. The purpose of writing this article is updated information of health professional practitioner about the plague, and bioterrorist aspect of this disease.
Material and Method: This study is a review article based on the information and data, which is published in the internet, journals and associated researches (2000- 2012).
Result: Plague or Black Death is an infectious disease shared between humans and animals and is potentially fatal. This disease continues to be endemic around the world and is still prevalent in more than 20 countries. Plague bacillus (Yersinia Pestis) disrupt normal immune response in the host body due to systemic spread, and between 2-10 days is fatal if untreated. Since the plague bacillus can be converted into aerosol, therefore, may be used as a biological weapon. Streptomycin is first choice and effective drug against the plague. The prognosis of the disease is different and Prevention can be done in three levels, which are discussed in detail in the text of article.
Conclusion: Risk of biological attacks is serious threat. Today, despite the progress of science and technology, human knowledge to predict the time and place of the occurrence of this type of attacks is relatively weak. Therefore, the officials and experts in this regard should be conscious and aware to prepare for the risk and effort to plan. |
|
| Keywords: Biological Attack, Bioterrorism, Plague |
|
|
Full-Text [PDF 171 kb]
(5087 Downloads)
|
Type of Study: Applicable |
Subject:
Special
Received: 2013/09/17 | Accepted: 2013/09/18 | Published: 2013/09/18
|
|
|
|
|
|
|
| Add your comments about this article |
|
|
|
